Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF

被引:340
作者
Nillesen, Suzan T. M.
Geutjes, Paul J.
Wismans, Ronnie
Schalkwijk, Joost
Daamen, Willeke F.
van Kuppevelt, Toin H.
机构
[1] Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Biochem 280, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Dermatol 370, NL-6500 HB Nijmegen, Netherlands
关键词
angiogenesis; growth factors; collagen; tissue response; biomaterial; tissue engineering;
D O I
10.1016/j.biomaterials.2006.10.029
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
An important issue in tissue engineering is the vascularisation of the implanted construct, which often takes several weeks. In vivo, the growth factors VEGF and FGF2 show a combined effect on both angiogenesis and maturation of blood vessels. Therefore, we hypothesise that the addition of these growth factors to an acellular construct increases blood vessel formation and maturation. To systematically evaluate the contribution of each scaffold component with respect to tissue response and in particular to blood vessel formation, five porous scaffolds were prepared and characterised, viz.: collagen, collagen with heparin, and collagen with heparin plus one or two growth factors (rrFGF2 and rrVEGF). Scaffolds were subcutaneously implanted in 3 months old Wistar rats. Of all scaffolds tested, the one with a combination of growth factors displayed the highest density of blood vessels (type IV collagen) and most mature blood vessels (smooth muscle actin). In addition, no hypoxic cells were found in this scaffold at day 7 and 21 (hypoxia inducible factor 1-alpha). These results indicate that the addition of both FGF2 and VEGF to an acellular construct enhances an early mature vasculature. This opens prospects for (acellular) tissue-engineered constructs in conditions as ischaemic heart disease or diabetic ulcers. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1123 / 1131
页数:9
相关论文
共 33 条
[1]   SYNERGISTIC EFFECT OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR ON ANGIOGENESIS IN-VIVO [J].
ASAHARA, T ;
BAUTERS, C ;
ZHENG, LP ;
TAKESHITA, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
CIRCULATION, 1995, 92 (09) :365-371
[2]  
Bancroft J. D., 1990, THEORY PRACTICE HIST
[3]   Growth factors in the treatment of diabetic foot ulcers [J].
Bennett, SP ;
Griffiths, GD ;
Schor, AM ;
Leese, GP ;
Schor, SL .
BRITISH JOURNAL OF SURGERY, 2003, 90 (02) :133-146
[4]   Novel angiogenic signaling pathways and vascular targets [J].
Bicknell, R ;
Harris, AL .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 :219-238
[5]   The well-tempered vessel [J].
Blau, HM ;
Banfi, A .
NATURE MEDICINE, 2001, 7 (05) :532-534
[6]   Building better vasculature [J].
Bruick, RK ;
McKnight, SL .
GENES & DEVELOPMENT, 2001, 15 (19) :2497-2502
[7]  
BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
[8]  
CALVANI M, 2005, BLOOD
[9]   Tissue response of defined collagen-elastin scaffolds in young and adult rats with special attention to calcification [J].
Daamen, WF ;
Nillesen, STM ;
Hafmans, T ;
Veerkamp, JH ;
van Luyn, MJA ;
van Kuppevelt, TH .
BIOMATERIALS, 2005, 26 (01) :81-92
[10]   Cross-linking of dermal sheep collagen using a water-soluble carbodiimide [J].
Damink, LHHO ;
Dijkstra, PJ ;
vanLuyn, MJA ;
vanWachem, PB ;
Nieuwenhuis, P ;
Feijen, J .
BIOMATERIALS, 1996, 17 (08) :765-773